FDA Adverse Event Malfunction Summary report: N

COBAS 6000 C501MODULE

MDR report key: 1898679 · Received November 15, 2010

Report

Report Number
1823260-2010-06730
Event Type
Malfunction
Date Received
November 15, 2010
Date of Event
October 21, 2010
Report Date
January 7, 2011
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JMG
PMA / PMN Number
K060373
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE SAMPLE WAS PROVIDED FOR INVESTIGATION. THE SAMPLE WAS TESTED USING A COBAS C501, USING FERRTIN REAGENT GENERATION 3 AND FERRITIN REAGENT GENERATION 4. THE SAMPLE WAS ALSO TESTED ON THE ELECSYS E411 ANALYZER, THE RESULTS FROM THE FERRITIN GENERATION 4 ASSAY WERE CONSISTENT TO THE FERRITIN RESULT ON THE ELECSYS E411. THE RESULT FROM THE GENERATION 4 ASSAY SHOULD BE RELIABLE. THE ROOT CAUSE FOR THE DIFFERENT RECOVERIES BETWEEN FERRITIN GENERATION 3 AND FERRITIN GENERATION 4 ASSAYS ON THE COBAS C501 INSTRUMENT MAY BE A SAMPLE SPECIFIC EFFECT, MOST LIKELY RELATED TO AN ENZYMATIC CLEAVAGE PROCESS, HOWEVER THIS COULD NOT BE CONFIRMED. NO ADVERSE EVENTS WERE REPORTED.

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED IN (B)(6).

Description of Event or Problem · 1

THE USER RECEIVED QUESTIONABLE RESULTS FOR ONE PATIENT SAMPLE WHILE PERFORMING A COMPARISON OF AT LEAST 12 SAMPLES USING DIFFERENT VERSIONS OF THE FERRITIN ASSAY. WITH THE FERRITIN GENERATION 3 REAGENT THE RESULT WAS 135 UG/L AND WITH THE FERRITIN GENERATION 4 REAGENT THE RESULT WAS 14.3 UG/L. THE RESULTS WERE NOT REPORTED OUTSIDE THE LABORATORY AS THE SAMPLES WERE TESTED FOR COMPARISON ONLY. NO ADVERSE EVENTS WERE ALLEGED REGARDING THE ISSUE. THE PATIENT'S CURRENT CONDITION WAS "GOOD". THE FERRITIN GENERATION 3 REAGENT LOT NUMBER WAS 625157 AND THE FERRITIN GENERATION 4 REAGENT LOT NUMBER WAS 627701.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 COBAS 6000 C501MODULE CLINICAL CHEMISTRY ANALYZER JMG ROCHE DIAGNOSTICS NA NA

Patients

Seq Age Sex Outcome Treatment
1 031 YR